Category Research

Augustine Therapeutics Secures EUR 17 Million in Series A Funding to Propel Lead Candidate into Clinical Development for Neurological Diseases

Augustine Therapeutics, a pioneering biotech firm dedicated to advancing treatments for neurodegenerative and cardiometabolic diseases, has successfully closed its Series A funding round with EUR 17 million (USD 18.5 million). Asabys Partners led the financing, joined by Eli Lilly and…

Read MoreAugustine Therapeutics Secures EUR 17 Million in Series A Funding to Propel Lead Candidate into Clinical Development for Neurological Diseases

BioStrand and PGxAI Partner to Develop AI Model for Pharmacogenomics with LENSai

ImmunoPrecise Antibodies Ltd. (IPA), an AI-driven biotherapeutic research and technology company, announced a strategic collaboration between its subsidiary, BioStrand, and PGxAI. This partnership aims to leverage BioStrand’s patented LENSai Foundation AI Model to advance pharmacogenomics, the study of how genetic…

Read MoreBioStrand and PGxAI Partner to Develop AI Model for Pharmacogenomics with LENSai

New Thermo Scientific Heracell Incubators Propel the Future of Fully Automated Labs

To advance workflow automation in cell therapy production, Thermo Fisher Scientific has launched the Thermo Scientific™ Heracell™ VIOS™ 250i AxD CO2 Incubators. These pioneering CO2 incubators are tailored for integration into automated and modular labs. Known for optimal cell growth…

Read MoreNew Thermo Scientific Heracell Incubators Propel the Future of Fully Automated Labs

MAIA Biotech’s Latest Advancements: Yearly Success and Breakthroughs in Cancer Treatment

MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, has announced its highlights and key achievements for the year so far, along with recent clinical progress regarding its lead candidate, THIO. THIO…

Read MoreMAIA Biotech’s Latest Advancements: Yearly Success and Breakthroughs in Cancer Treatment

Dr. Michael Donovan to Lead Personalized Cancer Therapy at Cellworks’ New CLIA Lab

A leader in Personalized Therapy Decision Support and Precision Drug Development, Cellworks, has announced the opening of a CLIA-certified computational laboratory in Franklin, Tennessee. Administered by the Centers for Medicare and Medicaid Services, CLIA (Clinical Laboratory Improvement Amendments) ensures high…

Read MoreDr. Michael Donovan to Lead Personalized Cancer Therapy at Cellworks’ New CLIA Lab